Sanofi-Aventis to buy Chattem for $1.9 bn

French drug maker Sanofi-Aventis SA to buy US health care company Chattem Inc for about $1.9 billion in cash.

PARIS: French drug maker Sanofi-Aventis SA says it has agreed to buy US health care company Chattem Inc for about $1.9 billion in cash. Sanofi-Aventis says the deal would create the world's fifth-largest consumer health care company.

Sanofi-Aventis, based in Paris, says it will offer $93.50 per share to acquire 100 percent of Chattem, maker of consumer health care products such as Gold Bond skin care creams and Icy Hot pain relief medicine.

In a statement Monday, Sanofi-Aventis said it will launch its public tender offer for Chattem in January. It expects to complete the acquisition in the first quarter of 2010.

Chattem is based in Chattanooga, Tenn.
Download
The Economic Times Business News App
for the Latest News in Business, Sensex, Stock Market Updates & More.
Download
The Economic Times News App
for Quarterly Results, Latest News in ITR, Business, Share Market, Live Sensex News & More.
READ MORE
ADVERTISEMENT

LOGIN & CLAIM

50 TIMESPOINTS

More from our Partners

Loading next story
Business News › News › International › Sanofi-Aventis to buy Chattem for $1.9 bn
Text Size:AAA
Success
This article has been saved

*

+